Under construction – not a live service
Sign in

ANCA-associated vasculitis

Current status: Treatable, not yet curable

A type of blood vessel inflammation (vasculitis) in which the immune system attacks healthy blood vessels, making them swollen and narrow.1 One form, granulomatosis with polyangiitis, mainly affects the ears, nose, sinuses, lungs and kidneys.2 Steroids with rituximab or another medicine that calms the immune system are used to bring it under control. Later, lower doses or a different medicine aim to stop it coming back.2 It mainly affects middle-aged or older people, and it can be fatal if it is not treated.1

Read more about ANCA-associated vasculitis
Where research stands todayUpdated 12 Nov 2026

Trial-stage treatments and research studies you can join

Filters

Country
City
Distance is calculated in your browser. Your city is not sent to us.
Type
Get notified of new trialsUnited States, all cities, all phases
Set up email alert
Your ageShows only trials that take people your age.
Phase

Where treatment stands

Treatment can bring the condition under control and keep it under control, but symptoms can come back.

Where research stands now

On 11 November 2026, 104 trials and studies of ANCA-associated vasculitis were open. On that day, 93 treatments were being tested in people: 15 in phase 3, the last large trials before approval, and 40 in phase 2. Articles published from 5 November 2025 to 11 November 2026 reported 7 studies of treatments in people, 6 in animals and 1 in the lab. On 11 November 2026, 4 medicines had a US approval and 3 had an EU approval for this disease.

Machine-written from the registry counts and the regulators' lists · 2026-11-11

We found 9 medicines approved for ANCA-associated vasculitis in the EU, the US, Switzerland or France.

Approved: 9

Officially approved for this disease in the EU, the US, Switzerland or France.

Where this comes from

The EU medicines agency (EMA) and its list of medicines in the EU, US prescribing labels (DailyMed, openFDA), the Swiss medicines register (Swissmedic), the French medicines database (ANSM) and the Health Canada drug database, checked on 11 November 2026. Every medicine links to its own official text.

A computer made this list from the official texts: it kept only medicines whose own approval text names the disease, wrote "Who it is for" from that text and checked it against the text a second time. People have not reviewed it yet.

Not medical advice. Talk to your doctor before you change any treatment.

Treatments approved outside the EU

Medicines for ANCA-associated vasculitis approved in the US or Japan that are not approved in the EU.

Checked on 11 Nov 2026 in the official lists of the US (FDA), Japan (PMDA, approvals since April 2004) and the EU (EMA). 2 uncertain matches are left out.

Check with your insurance

Your health insurer may pay part of the cost, sometimes all of it. This depends on your insurer, your plan and the country, so always ask your insurer before you go. For planned care in the EU, the EEA and Switzerland, ask about form S2.

Support organisations

Patient organisations and helplines in United States, for you and your family.

ANCA-associated vasculitis organisations in United States

  • Vasculitis Foundation

    US-based nonprofit that supports, educates and empowers people with vasculitis, including ANCA-associated vasculitis, and funds research.

  • National Organization for Rare Disorders

    US national rare disease alliance of patient organizations: education, patient assistance programs, rare disease database and policy advocacy.

General support in United States

  • 988 Suicide & Crisis Lifeline

    US national 24/7 free and confidential lifeline for anyone in suicidal crisis or emotional distress, reachable by calling or texting 988 or by chat.

  • MedlinePlus

    Free, easy-to-read health information service of the US National Library of Medicine (NIH) on diseases, conditions, drugs and wellness.

International

General support

  • European Patients' Forum (EPF)

    Umbrella of European patient organisations and national patient coalitions.

  • International Alliance of Patients' Organizations

    Global alliance of patient organisations of all diseases, promoting patient-centred healthcare.

Patient organisation umbrella bodies

Offer tissue or data

There are three ways to help research move faster.

Give tissue or bloodA biobank stores your sample so many research teams can use it.No open programme yet
Share your health dataA patient registry collects your health data, without your name, for research.How to join
Take part as a healthy volunteerStudies also need people without the disease, for comparison. Family and friends can help.Volunteer

“Miracle cure” fact checker

Social media spreads misinformation. Paste what you read here, and we'll tell you whether there is scientific evidence behind it.

What you paste is checked with AI (Anthropic, USA) and is not stored. Please leave out names and other personal details.

“Cures” others already fact-checked

See all 4

Before you pay for anything, ask three things

  1. Is there a published study in people?
  2. Can I have the full price in writing?
  3. What does my doctor say?

About ANCA-associated vasculitis

What is it?

Vasculitis means inflammation of the blood vessels: the immune system attacks healthy blood vessels, which become swollen and narrow.1,3 ANCA are antibodies that can be found in the blood. About 9 in 10 people with granulomatosis with polyangiitis (GPA) have them.4,2 The forms include GPA, which mainly affects the ears, nose, sinuses, lungs and kidneys; microscopic polyangiitis (MPA), which often affects the lungs, kidneys and nerves; and eosinophilic granulomatosis with polyangiitis (EGPA), which can cause asthma.2,1

GPA is rare: it affects about 3 in 100,000 people in the United States.4,2 GPA mainly affects middle-aged or older people; MPA most often develops in middle-aged people; EGPA mainly affects adults around 38 to 54.1 Most people with GPA have no family history of it; genes and things in the environment probably act together.4

The first signs

The signs can come on slowly over months or suddenly.2 Early, general signs can be mild:2

  • fever, night sweats, tiredness and weakness;2
  • joint pain, loss of appetite and weight loss;2
  • a blocked or runny nose with bloody crusts, nosebleeds or sinus pain;2
  • ear infections or hearing loss, or eye problems such as conjunctivitis, swollen eyelids or blurred vision;2
  • a cough that does not go away, coughing up blood, or shortness of breath.2

The kidneys can be affected, which may cause high blood pressure, swollen legs or kidney failure.2

How doctors find out

There is no single test, and it can be hard to diagnose.2 Your family doctor asks about your symptoms and may examine you. If they think you could have GPA, they send you to a specialist.2 A blood test looks for an antibody called ANCA, which may be a sign of GPA.2 A small piece of tissue from an affected area may be tested (a biopsy).2 You may have an X-ray, CT scan or MRI scan of the affected body parts, and a urine test if you have kidney symptoms.2

Current treatment

Steroids with methotrexate (milder disease), rituximab (severe disease) or cyclophosphamide bring it under control, followed by lower doses or another medicine to prevent relapse.Source: NHS

Will it get worse?

Without treatment it is serious: it can lead to organ failure and can be fatal.1 Treatment aims to bring it under control. If your symptoms come back (a relapse), your treatment may be changed or restarted.2

Medicines: what helps, and what to watch for

A specialist leads treatment, which depends on how severe it is and which parts of the body are affected.2 It has two stages.2 First, the inflammation is brought under control: steroids, sometimes with methotrexate for milder disease, or with the biological medicine rituximab for severe disease; cyclophosphamide, a chemotherapy-type medicine, may also be used.2 Then, lower doses or a different medicine help stop it coming back.2

Good to know:

  • if it comes back, your treatment may be changed or started again;2

Dialysis, a transplant or surgery, for some people

In very severe cases that affect the kidneys, you may need dialysis or a kidney transplant.2 You may need surgery if you have complications, for example to rebuild the bridge of the nose if it has been damaged.2